Xvivo Perfusion AB
XVIVO.ST
#5752
Rank
A$1.30 B
Marketcap
$41.44
Share price
-3.98%
Change (1 day)
2.07%
Change (1 year)
Categories

Earnings for Xvivo Perfusion AB (XVIVO.ST)

Earnings in 2024 (TTM): A$5.56 Million

According to Xvivo Perfusion AB's latest financial reports the company's current earnings are A$73.21 Million. In 2023 the company made an earning of A$0.52 Million a decrease over its 2022 earnings that were of A$3.81 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xvivo Perfusion AB from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$5.56 M958.1%
2023 A$0.52 M-86.2%
2022 A$3.81 M226.49%
2021 A$1.16 M-110.72%
2020 -A$10.9 Million-1221.07%
2019 A$0.97 M-70.61%
2018 A$3.3 M117.32%
2017 A$1.52 M146.09%
2016 A$0.61 M-61.52%
2015 A$1.6 M-3.88%
2014 A$1.67 M-39.59%
2013 A$2.76 M